Open-label study of olanzapine in children with pervasive developmental disorder.

C, Kemner; SH, Willemsen-Swinkels; Jonge M, de; H, Tuynman-Qua; Engeland H, van

doi:10.1097/00004714-200210000-00003

Public

Open-label study of olanzapine in children with pervasive developmental disorder.

Shared by NobleBlocks on Oct 1, 2002 • 12:00 AM UTC

Authors:

Kemner C

Willemsen-Swinkels SH

de Jonge M

Abstract

The effects of olanzapine on the symptomatology of children with pervasive developmental disorder with emphasis on problems of communication and the safety of the drug were investigated in a 3-month open-label, open-dosage study. Participating in the study were 25 children age 6 to 16 years with a d...

Discussions